Guest guest Posted July 31, 2008 Report Share Posted July 31, 2008 Perspectives in the Treatment and Prophylaxis of Cytomegalovirus Disease in Solid-Organ Transplant Recipients. Therefore, new therapeutic agents for CMV and an immunogenic, safe CMV vaccine are critically needed…… http://www.ncbi.nlm.nih.gov/pubmed/18652557?dopt=Abstract Barb in Texas - Together in the Fight.... Whatever it Takes! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.